EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Interplay of Inflammation and Gut-Microbiota Dysbiosis in Alzheimer’s Disease: Mechanisms and Therapeutic Potential

Hanis Nabilah Abdol Samat, Nurul Nadirah Razali iD, Hazlina Mahadzir iD, Tengku Sifzizul Tengku Muhammad, King-Hwa Ling iD, Nur Izzati Mansor, Shahidee Zainal Abidin iD

International Journal of Molecular Sciences · 12.09.2025 · 26 (18) · 8905

DOI: 10.3390/ijms26188905 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.09.2025. Verfasst von Hanis Nabilah Abdol Samat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science and Marine Environment, Universiti Malaysia Terengganu, Kuala Nerus 21030, Terengganu, Malaysia. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Dysbiosis, Alzheimer Disease, Neuroinflammatory Diseases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) represents a major global health challenge, characterised by progressive neurodegeneration that leads to cognitive decline. Inflammation is a key factor in the pathogenesis of AD, affecting both neuroinflammation and systemic inflammation. In AD, neuroinflammation is marked by the activation of microglia and the release of pro-inflammatory cytokines, which exacerbate neuronal damage and cognitive deficits. Systemic inflammation further compromises the blood–brain barrier (BBB), increasing its permeability and permitting the entry of inflammatory molecules and immune cells into the brain, thereby advancing the disease’s hallmark features. Recent studies have elucidated the influence of gut microbiota dysbiosis on AD and inflammation. This imbalance is thought to be associated with alterations in the concentrations of short-chain fatty acids (SCFAs) and bile acids, which can modulate neuroinflammation and contribute to AD pathology. Additionally, imbalances in neurotransmitters resulting from gut microbiota dysbiosis can further disrupt brain function and facilitate AD progression. This review provides an overview of the hypothesis that systemic and central nervous system (CNS) inflammation, together with gut-microbiota dysbiosis, may interact to influence the development and progression of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDysbiosisAlzheimer DiseaseNeuroinflammatory DiseasesFatty Acids, VolatileBrain-Gut AxisBile Acids and SaltsNeurotransmitter AgentsDisease ProgressionHumansBlood-Brain Barrier

Stichwörter der Autor:innen

Alzheimer’s diseasegut microbiota dysbiosisgut microbiota metaboliteneuroinflammationsystemic inflammation

Substanzen

Fatty Acids, VolatileBile Acids and SaltsNeurotransmitter Agents

Autor:innen und Institutionen

  • Faculty of Science and Marine Environment, Universiti Malaysia Terengganu, Kuala Nerus 21030, Terengganu, Malaysia.
  • Department of Medicine, Hospital Canselor Tuanku Muhriz, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras 56000, Kuala Lumpur, Malaysia.
  • Institute of Climate Adaptation and Marine Biotechnology, Universiti Malaysia Terengganu, Kuala Nerus 21030, Terengganu, Malaysia.
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.
  • Malaysian Research Institute on Ageing (MyAgeing®), Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.
  • Department of Nursing, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras 56000, Kuala Lumpur, Malaysia.

ORCID-Profile: Nurul Nadirah Razali, Hazlina Mahadzir, King-Hwa Ling, Shahidee Zainal Abidin

Förderung

  • Ministry of Higher Education

Zitieren

APA

Abdol Samat, H. N., Razali, N. N., Mahadzir, H., Tengku Muhammad, T. S., Ling, K. H., Mansor, N. I., & Abidin, S. Z. (2025). The Interplay of Inflammation and Gut-Microbiota Dysbiosis in Alzheimer’s Disease: Mechanisms and Therapeutic Potential. International Journal of Molecular Sciences, 26(18), 8905. https://doi.org/10.3390/ijms26188905

Vancouver

Abdol Samat HN, Razali NN, Mahadzir H, Tengku Muhammad TS, Ling KH, Mansor NI, et al. The Interplay of Inflammation and Gut-Microbiota Dysbiosis in Alzheimer’s Disease: Mechanisms and Therapeutic Potential. International Journal of Molecular Sciences. 2025;26(18):8905. doi:10.3390/ijms26188905

BibTeX
@article{AbdolSamat2025,
  author = {Abdol Samat, Hanis Nabilah and Razali, Nurul Nadirah and Mahadzir, Hazlina and Tengku Muhammad, Tengku Sifzizul and Ling, King-Hwa and Mansor, Nur Izzati and Abidin, Shahidee Zainal},
  title = {The Interplay of Inflammation and Gut-Microbiota Dysbiosis in Alzheimer’s Disease: Mechanisms and Therapeutic Potential},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {18},
  pages = {8905},
  doi = {10.3390/ijms26188905}
}
Kostenlos starten →